We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Colorimetric Test Devised for Tuberculosis in Developing Areas

By LabMedica International staff writers
Posted on 28 Dec 2015
A rapid, sensitive and low-cost method has been devised for detecting tuberculosis (TB), a highly infectious disease and a major global health problem, especially in countries with developing health care systems. More...


The typical way that physicians screen for TB, which is caused by the bacterium Mycobacterium tuberculosis (Mtb), is with a tuberculin skin test or an examination of a patient's sputum under a microscope. To weed out false positives, a more reliable test that involves growing Mtb cultures can be performed, but that requires weeks to complete.

Scientists at the Australian Institute for Bioengineering and Nanotechnology (St Lucia, QLD, Australia) and their colleagues began with a newly created nucleic acid amplification test that does not require expensive laboratory equipment to detect Mtb, but this modified test typically uses costly fluorescence technology to read the results. The team substituted the fluorescence detector with a colorimetric assay that changes to a blue hue if the infection is present, allowing health care workers to identify positive test results right away with the naked eye.

The team employed a modified Solid Phase Reversible Immobilization (SPRI) protocol) with Guanidium-HCl lysis buffer to sample for genomic DNA (gDNA) from Mtb cells. Nucleic acid amplification was performed with the TwistAmp Basic RPA Kit (TwistDx Limited; Cambridge, UK). They devised a simple colorimetric assay that utilizes the chemical oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) by isothermally functionalized DNA targets as a sensitive and specific biosensor for the detection of tuberculosis. Absorbance was determined with the ND-1000spectrophotometer (NanoDrop; Wilmington, DE, USA). Ampometry responses were measured on a workstation potentiostat (CH Instruments; Austin, TX, USA).

The team demonstrated how the modified diagnostic could be put on cheap, disposable electrochemical sensors for increased sensitivity, even in the field. Because the assay is inexpensive, quick and highly specific for the Mtb bacterium, the scientists say it could have a big impact in low-resource communities. The assays are inexpensive at USD 3.00, takes only 75 minutes, sensitive as approaching a single cell, and highly specific to M. tuberculosis. The study was published on November 30, 2015, in the journal ACS Sensors.

Related Links:

Australian Institute for Bioengineering and Nanotechnology 
TwistDx Limited 
NanoDrop



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.